This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. advanced 3.4% to $591.01 on what proved to be an all-around poor trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 44,938.31 and the S&P 500 Index falling 0.2% to 6,395.78.
The stock's rise snapped a two-day losing streak.
Regeneron Pharmaceuticals Inc. closed 51.2% below its 52-week high of $1,211.20, which the company reached on August 27th.
The stock outperformed some of its competitors, as Amgen Inc. rose 0.3% to $296.45, Moderna Inc. fell 3.7% to $26.89, and Gilead Sciences Inc. rose 0.64% to $118.73.
Trading volume totaled 1.3 million, compared to the 50-day average of 1.0 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 20, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.